Data is being collected. The dashboard will appear when it is available.
SYMBOL
Data is being collected. The dashboard will appear when it is available.
SOLV

Close price

$73.99

Latest price

$76.00

Change vs close

+2.72%

Current price: $76.00

Market cap

13.09B

Pre-market and after-hours data may be partial or delayed depending on the source and licensing.

Solventum Corporation

SOLV

NYSE · Health Care · Medical/Dental Instruments

Company Profile

At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better - while empowering healthcare professionals to perform at their best.

Website

https://www.solventum.com

Country

MN

Sector

Health Care

Industry

Medical/Dental Instruments

CIK

0001964738

Candlestick Chart

1D · Data source: loading

Loading candle data

Quarterly Performance Snapshot

Actual revenue and net income based on quarterly filings

Q2 Aug 2026

Quarterly Snapshot

Q2 Aug 2026

Mix

15.62B

Market cap

83.79%

13.09B

Expected quarterly revenue

14.07%

2.2B

Estimated quarterly net income

2.14%

334.39M

Market cap / expected revenue

5.95x

Revenue

Forecast

2.2B

Previous quarter

+9.56%

Net income

Forecast

334.39M

Previous quarter

+2,472.24%

Revenue and Net Income Trend

RevenueNet income

Quarterly Performance

13 quarters

Financial Statements

SEC Filings

12 filings shown

Open the original SEC filings to view the full document.

FormFiling DateReport DateAccessionLink
8-KJun 5, 2026Jun 2, 20260001964738-26-000036Document
SDMay 29, 2026No data0001964738-26-000033Document
8-KMay 27, 2026May 21, 20260001964738-26-000031Document
8-KMay 20, 2026May 15, 20260001964738-26-000027Document
4May 18, 2026May 15, 20260001474632-26-000008Document
4May 18, 2026May 15, 20260001110753-26-000006Document
4May 18, 2026May 15, 20260001587697-26-000008Document
4May 18, 2026May 15, 20260001958161-26-000009Document
4May 18, 2026May 15, 20260001222831-26-000012Document
4May 18, 2026May 15, 20260001337906-26-000006Document
4May 18, 2026May 15, 20260001161660-26-000007Document
4May 18, 2026May 15, 20260001808438-26-000007Document

Latest News

12 articles
ZacksJun 9, 2026, 12:00 AMnasdaq

Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Open article
ZacksJun 8, 2026, 12:00 AMnasdaq

Solventum Trends for 2026: AI Coding, Tariffs, and Margins

SOLV heads into 2026 balancing AI coding growth, cost savings, tariff pressure and a potential 2027 margin risk tied to its 3M supply deal.

Open article
ZacksJun 5, 2026, 12:00 AMnasdaq

Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?

Cencora (COR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Open article
MarketBeatMay 17, 2026, 12:00 AMnasdaq

Target the Red-Hot Spin-Off and Merger Space With These ETFs

Spin-offs and mergers may appeal to investors because they can signal a company's efforts to focus its business, realign its operations, or even seek new leadership. In the case of large conglomerates, it can be hard for investors to accurately assess which units might be the mo

Open article
FintelMay 15, 2026, 12:00 AMnasdaq

Wedbush Initiates Coverage of Solventum (SOLV) with Outperform Recommendation

Fintel reports that on May 15, 2026, Wedbush initiated coverage of Solventum (NYSE:SOLV) with a Outperform recommendation. Analyst Price Forecast Suggests 11.52% Upside

Open article
ZacksMay 15, 2026, 12:00 AMnasdaq

SOLV or HQY: Which Is the Better Value Stock Right Now?

SOLV vs. HQY: Which Stock Is the Better Value Option?

Open article
ZacksMay 12, 2026, 12:00 AMnasdaq

Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average

Should investors be excited or worried when a stock crosses above the 200-day simple moving average?

Open article
ZacksMay 7, 2026, 12:00 AMnasdaq

Why Solventum (SOLV) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Open article
ZacksMay 6, 2026, 12:00 AMnasdaq

Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates

SOLV beats Q1 earnings and revenue estimates as growth in MedSurg, Dental and HIS offset sales decline and margin pressure.

Open article
The Motley FoolMay 6, 2026, 12:00 AMnasdaq

Solventum (SOLV) Q1 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo

Open article
ZacksMay 6, 2026, 12:00 AMnasdaq

Solventum (SOLV) Recently Broke Out Above the 20-Day Moving Average

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

Open article
ZacksMay 6, 2026, 12:00 AMnasdaq

Solventum (SOLV) Recently Broke Out Above the 50-Day Moving Average

Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?

Open article